GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adbiotech Co Ltd (XKRX:179530) » Definitions » Capex-to-Revenue

Adbiotech Co (XKRX:179530) Capex-to-Revenue : 0.00 (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Adbiotech Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Adbiotech Co's Capital Expenditure for the three months ended in Mar. 2024 was ₩-8.74 Mil. Its Revenue for the three months ended in Mar. 2024 was ₩2,930.34 Mil.

Hence, Adbiotech Co's Capex-to-Revenue for the three months ended in Mar. 2024 was 0.00.


Adbiotech Co Capex-to-Revenue Historical Data

The historical data trend for Adbiotech Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adbiotech Co Capex-to-Revenue Chart

Adbiotech Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
0.01 0.54 0.30 0.07 0.03

Adbiotech Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.10 0.03 -0.07 -

Competitive Comparison of Adbiotech Co's Capex-to-Revenue

For the Biotechnology subindustry, Adbiotech Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adbiotech Co's Capex-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adbiotech Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Adbiotech Co's Capex-to-Revenue falls into.



Adbiotech Co Capex-to-Revenue Calculation

Adbiotech Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-289.898) / 10471.95
=0.03

Adbiotech Co's Capex-to-Revenue for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-8.74) / 2930.338
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adbiotech Co  (XKRX:179530) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Adbiotech Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Adbiotech Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Adbiotech Co (XKRX:179530) Business Description

Traded in Other Exchanges
N/A
Address
39, Geodudanji 1-gil, Dongnae-myeon, Gangwon-do, Chuncheon, KOR, 24398
Adbiotech Co Ltd is a life science company. It develops a vaccine and antibiotic-friendly substances such as IgY, Immunoglobulin in Yolk for human, animal and fish oral antibody products, and functional cosmetics and food additives. The company aim to develop Helico IgY, Cholesterol IgY, and Ulcerative Colitis natural product medicines.

Adbiotech Co (XKRX:179530) Headlines

No Headlines